{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:51:40Z","timestamp":1791204700529,"version":"4.2.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The 2022 mpox outbreak represented a major shift in transmission dynamics, with sustained community spread occurring in several nonendemic countries, including the United Kingdom. Examining how nonendemic health systems responded to this outbreak is essential for strengthening preparedness for future emerging and re-emerging infectious diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A scoping review was conducted in accordance with the Preferred Reporting Items for Systematic and Meta-Analysis Extension for Scoping Reviews guidelines to synthesize evidence on the UK healthcare system\u2019s response to the 2022 mpox outbreak. Electronic databases and gray literature sources were searched for publications released between January and December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Evidence was mapped across seven World Health Organization-aligned intervention domains relevant to outbreak preparedness and response. Eleven sources were included, comprising peer-reviewed studies and policy-relevant gray literature. Evidence was most frequently reported for infection prevention and control (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 7), systems for identifying emerging and re-emerging infections (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6), and rapid data sharing and risk communication (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 5). Moderate evidence addressed community engagement (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 5) and vaccine and therapeutic capacity (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 5). In contrast, only one source examined laboratory systems (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1), and no studies described structured surge capacity training for healthcare workers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The UK response to the 2022 mpox outbreak demonstrated timely coordination, effective surveillance, and implementation of infection prevention measures in a nonendemic setting. However, important limitations remain, particularly in workforce surge capacity, domestic vaccine manufacturing, and evidence on postexposure vaccination effectiveness. Addressing these gaps is essential for strengthening health system resilience and preparedness for future outbreaks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jgid.jgid_215_25","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:00:21Z","timestamp":1790748021000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The UK Health System\u2019s Response to the Monkeypox Outbreak of 2022: A Scoping Review"],"prefix":"10.4103","volume":"18","author":[{"given":"Harris","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Adult Social Care, Harrow Council, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Kumar Sarker","family":"Rony","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia","family":"Aranha","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20261005","doi-asserted-by":"crossref","first-page":"20160297","DOI":"10.1098\/rstb.2016.0297","article-title":"The Ebola outbreak, 2013-2016: Old lessons for new epidemics","volume":"372","author":"Coltart","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R2-20261005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"R3-20261005","first-page":"88","year":"2022","journal-title":"Weekly Epidemiological Update on COVID-19 \u2013 20 April World Health Organization"},{"key":"R4-20261005","first-page":"459","article-title":"Clinico-epidemiological features of monkeypox patients with an animal or human source of infection","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"R5-20261005","first-page":"372","article-title":"Human monkeypox disease (MPX)","volume":"30","author":"Farahat","year":"2022","journal-title":"Infez Med"},{"key":"R6-20261005","first-page":"537","article-title":"Multistate outbreak of monkeypox-Illinois, Indiana, and Wisconsin, 2003","volume":"52","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"key":"R7-20261005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a traveler returning from Nigeria \u2013 Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"R8-20261005","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3201\/eid2808.220830","article-title":"Imported monkeypox from international traveler, Maryland, USA, 2021 (response)","volume":"28","author":"Costello","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"R9-20261005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/1995-7645.346081","article-title":"Emergence of monkeypox: Another concern amidst COVID-19 crisis","volume":"15","author":"Shanmugaraj","year":"2022","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"R10-20261005","doi-asserted-by":"crossref","first-page":"e1011463","DOI":"10.1371\/journal.pcbi.1011463","article-title":"Nowcasting the 2022 mpox outbreak in England","volume":"19","author":"Overton","year":"2023","journal-title":"PLoS Comput Biol"},{"key":"R11-20261005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"R12-20261005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1017\/ice.2022.167","article-title":"Development and deployment of tools for rapid response notification of Monkeypox exposure, exposure risk assessment and stratification, and symptom monitoring","volume":"43","author":"Simpson","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R13-20261005","doi-asserted-by":"crossref","first-page":"1060678","DOI":"10.3389\/fpubh.2022.1060678","article-title":"Useful public health countermeasures to control the current multicountry outbreak of Monkeypox disease","volume":"10","author":"Diatta","year":"2022","journal-title":"Front Public Health"},{"key":"R14-20261005","first-page":"104049","article-title":"Rise of monkeypox: Lessons from COVID-19 pandemic to mitigate global health crises","volume":"79","author":"Ennab","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R15-20261005","journal-title":"Next Generation Sequencing"},{"key":"R16-20261005","first-page":"104069","article-title":"The outbreak of monkeypo\u00d72022: An overview","volume":"79","author":"Hraib","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R17-20261005","year":"2015","journal-title":"Contacts: UKHSA Health Protection Teams: GOV.UK"},{"key":"R18-20261005","doi-asserted-by":"crossref","first-page":"100553","DOI":"10.1016\/j.bj.2022.07.007","article-title":"Current efforts and challenges facing responses to Monkeypox in United Kingdom","volume":"46","author":"Idris","year":"2023","journal-title":"Biomed J"},{"key":"R19-20261005","first-page":"81","article-title":"Rapid reconfiguration of sexual health services in response to UK autochthonous transmission of mpox (monkeypox)","volume":"99","author":"Heskin","year":"2023","journal-title":"Sex Transm Infect"},{"key":"R20-20261005","journal-title":"Mpox: Guidance GOV.UK 2022a"},{"key":"R21-20261005","journal-title":"Mpox Control: UK Strategy 2022 to 2023 GOV.UK: GOV.UK; 2022b"},{"key":"R22-20261005","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1002\/hsr2.1030","article-title":"Decreasing trend of monkeypox cases in Europe and America shows hope for the world: Evidence from the latest epidemiological data","volume":"6","author":"Khan","year":"2023","journal-title":"Health Sci Rep"},{"key":"R23-20261005","doi-asserted-by":"crossref","first-page":"102540","DOI":"10.1016\/j.tmaid.2022.102540","article-title":"The 2022 monkeypox outbreak: A UK military perspective","volume":"52","author":"Woolley","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R24-20261005","doi-asserted-by":"crossref","first-page":"2200422","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","article-title":"Community transmission of monkeypox in the United Kingdom, April to May 2022","volume":"27","author":"Vivancos","year":"2022","journal-title":"Euro Surveill"},{"key":"R25-20261005","doi-asserted-by":"crossref","first-page":"100114","DOI":"10.1016\/j.jcvp.2022.100114","article-title":"Monkeypox: EpiMPX surveillance system and open data with a special focus on European and Italian epidemic","volume":"2","author":"Branda","year":"2022","journal-title":"J Clin Virol Plus"},{"key":"R26-20261005","doi-asserted-by":"crossref","first-page":"e073153","DOI":"10.1136\/bmj-2022-073153","article-title":"Transmission dynamics of monkeypox in the United Kingdom: Contact tracing study","volume":"379","author":"Ward","year":"2022","journal-title":"BMJ"},{"key":"R27-20261005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.eimc.2022.08.002","article-title":"Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey","volume":"41","author":"Grothe","year":"2023","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"R28-20261005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.12688\/f1000research.125893.1","article-title":"Rapid review on monkeypox policies among the G20 nations: Relevance to policy and practitioner","volume":"11","author":"Dsouza","year":"2022","journal-title":"F1000Res"},{"key":"R29-20261005","year":"2022","journal-title":"NHS Launches New Online Site Finder for Monkeypox Vaccines: NHS England"},{"key":"R30-20261005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.7861\/clinmed.2022-0251","article-title":"Where now for infection services in the NHS? How lessons from the pandemic should drive long-overdue integration of microbiology and infectious diseases","volume":"22","author":"Llewelyn","year":"2022","journal-title":"Clin Med (Lond)"},{"key":"R31-20261005","doi-asserted-by":"crossref","DOI":"10.19088\/SSHAP.2022.020","author":"Schmidt-Sane","year":"2022","journal-title":"RCCE strategies for monkeypox response"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_215_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:00:33Z","timestamp":1791201633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_215_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jgid.jgid_215_25","relation":{},"ISSN":["0974-777X","0974-8245"],"issn-type":[{"value":"0974-777X","type":"print"},{"value":"0974-8245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}